dsdsa

product

100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Dedicated to strict top quality command and considerate purchaser support, our experienced staff customers are always available to discuss your necessities and be certain full client gratification for Osimertinib, Oxaliplatin, China Diclofenac Sodium, We have been normally seeking forward to forming profitable company relationships with new clientele around the environment.
100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai Detail:

Product name Docetaxel Trihydrate
Synonyms (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3)
CAS No. 148408-66-6
Appearance White to off-white crystalline powder
Molecular Formula C43H53NO14.3(H2O)
Molecular Weight 861.94
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Docetaxel Trihydrate CAS# 148408-66-6

ITEMS

STANDARDS

RESULTS

Characters A:White to off-white crystalline powder Conforms
B:Solubility :Insoluble in water ,soluble in ethanol and acetone   Conforms
Specific Rotation             ﹣38.5°~﹣41.5° ﹣40°
Identification 1.IR:  The same to check sample    Conforms
2.UV:  λmax232nm    Conforms
  1. Colour reactions: positive reactions
   Conforms
  1. HPLC: retention times is same as the standard sample
   Conforms
Impurities Total impurities: NMT 1.0% 0.29%
Impurities A: NMT 0.5% 0.0551%
Impurities B: NMT 0.3% 0.0470%
Impurities C: NMT 0.3% 0.0535%
Any other single impurity: NMT 0.1% 0.0702%
Water 5.0% – 7.0% 6.15%
Residue on ignition NMT 0.1% w/w 0.03%
Heavy metal NMT 20ppm Conforms
Assay 97.5%~ 102.0% 99.7%
Conclusion

It meets EP7.5.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures


Related Product Guide:

Good quality comes to start with; service is foremost; organization is cooperation" is our enterprise philosophy which is regularly observed and pursued by our firm for 100% Original Ruxolitinib - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai , The product will supply to all over the world, such as: Adelaide, Manchester, Sierra Leone, The best and original quality for spare parts is a most important factor for transportation. We may stick on supplying original and good quality parts even a little profit earned. God will bless us to do kindness business forever.
  • Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
    5 Stars By Rebecca from Egypt - 2018.11.06 10:04
    The company's products very well, we have purchased and cooperated many times, fair price and assured quality, in short, this is a trustworthy company!
    5 Stars By Chloe from South Africa - 2018.03.03 13:09
    Write your message here and send it to us